International Conferences

Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer


Recommended Conferences for Diabetes Medicines

Diabetes Medicines

As per available reports about 12 relevant journals, 72 Conferences, 69 workshops are presently dedicated exclusively to Diabetes Medicines and about 1069 articles are being published on Diabetes Medicines

Diabetes means your blood glucose, or blood sugar, levels are too high. If you can't control your diabetes with wise food choices and physical activity, you may need diabetes medicines. The kind of medicine you take depends on your type of diabetes, your schedule, and your other health conditions. With type 1 diabetes, your pancreas does not make insulin. Insulin is a hormone that helps glucose gets into your cells to give them energy. Without insulin, too much glucose stays in your blood. If you have type-1 diabetes, you need to take insulin. Type-2 diabetes, the most common type, can start when the body doesn't use insulin as it should. Topics related to conferences are Diabetes and its Complications, Complications associated with diabetes, Advanced Technologies for Treatment of Diabetes, Transplantation for Diabetes, Islet Transplantation and Beta cell targeting

OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.

Scope and Importance:

Studies have shown that some diabetes pills may help prevent diabetes and diabetes-related complications. Both metformin and Precose have been shown to reduce a person's risk of developing type 2 diabetes, particularly when combined with lifestyle changes such as a proper diet and regular exercise program. Actos has been shown to reduce the risk of heart attack, stroke, and premature death in those with type 2 diabetes. Researchers continue to look into the preventative benefits of other medications.

If your body can't keep up with the need for insulin, you may need to take pills. Along with meal planning and physical activity, diabetes pills help people with type 2 diabetes or gestational diabetes keep their blood glucose levels on target. Several kinds of pills are available. Each works in a different way. Many people take two or three kinds of pills. Some people take combination pills. Combination pills contain two kinds of diabetes medicine in one tablet. Some people take pills and insulin.

Drug treatment for Type 1 diabetes:

Insulin injected subcutaneously is the first-line treatment of type 1 diabetes mellitus (DM). The different types of insulin vary with respect to onset and duration of action. Short-, intermediate-, and long-acting insulins are available.

Short-acting and rapid-acting insulins are the only types that can be administered intravenously (IV). Human insulin currently is the only species of insulin available in the United States; it is less antigenic than the previously used animal-derived varieties.

Rapid-acting insulins are used whenever a rapid onset and short duration are appropriate (eg, before meals or when the blood glucose level exceeds target and a correction dose is needed). Rapid-acting insulins are associated with less hypoglycemia than regular insulin.

Currently, short-acting insulins are less commonly used than the rapid-acting insulins in patients with type 1 DM. They are used when a slightly slower onset of action or a greater duration of action is desired.

Intermediate-acting insulins have a relatively slow onset of action and a relatively long duration of action. They are usually combined with faster-acting insulins to maximize the benefits of a single injection.

Long-acting insulins have a very long duration of action and, when combined with faster-acting insulins, provide better glucose control for some patients. In patients with type 1 DM, they must be used in conjunction with a rapid-acting or short-acting insulin given before meals.

Premixed insulins contain a fixed ratio of rapid-acting insulins with longer-acting insulin, which can restrict their use. Premixed insulin is usually not recommended in type 1 DM patients, because of their need for frequent adjustments of premeal insulin doses

Types of Diabetes Pills for Type 2 Daibetes:

Diabetes pills are grouped in categories. There are several categories of diabetes pills. Each works differently. Sulfonylureas: These diabetes pills lower blood sugar by causing the pancreas to release more insulin. The first drugs of this type that were developed -- Dymelor (acetohexamide), Diabinese (chlorpropamide), Orinase (tolbutamide), and Tolinase (tolazamide) -- are not as widely used since they tend to be less potent and shorter-acting drugs than the newer sulfonylureas. They include Glucotrol (glipizide), Glucotrol XL (extended release), DiaBeta (glyburide), Micronase (glyburide), Glynase PresTab (glyburide), and Amaryl (glimepiride). These drugs can cause a decrease in the hemoglobin A1c (HbA1c) of up to 1%-2%. Biguanides: These diabetes pills improve insulin's ability to move sugar into cells especially into the muscle cells. They also prevent the liver from releasing stored sugar. Biguanides should not be used in people who have kidney damage or heart failure because of the risk of precipitating a severe build up of acid (called lactic acidosis) in these patients. Biguanides can decrease the HbA1c 1%-2%. An example includes metformin (Glucophage, Glucophage XR, Riomet, Fortamet, and Glumetza). Thiazolidinediones: These diabetes pills improve insulin's effectiveness in muscle and in fat tissue. They lower the amount of sugar released by the liver and make fat cells more sensitive to the effects of insulin. Actos (pioglitazone) and Avandia (rosiglitazone) are the two drugs of this class. A decrease in the HbA1c of 1%-2% can be seen with this class of oral diabetes medications. These drugs may take a few weeks before they have an effect in lowering blood sugar. All patients using Avandia must review and fully understand the risks to the heart. Alpha-glucosidase inhibitors: including Precose (acarbose) and Glyset (miglitol). These drugs block enzymes that help digest starches, slowing the rise in blood sugar. These diabetes pills may cause diarrhea or gas. They can lower hemoglobin A1c by 0.5%-1%. Meglitinides: including Prandin (repaglinide) and Starlix (nateglinide). These diabetes medicines lower blood sugar by stimulating the pancreas to release more insulin. The effects of these diabetes pills depend on the level of glucose. They are said to be glucose dependent. High sugars make this class of diabetes medicines release insulin. This is unlike the sulfonylureas that cause an increase in insulin release, regardless of glucose levels, and can lead to hypoglycemia. Dipeptidyl peptidase IV (DPP-IV) inhibitors, including Januvia (sitagliptin), Nesina (alogliptin), Onglyza (saxagliptin), and Tradjenta (linagliptin). The DPP-IV inhibitors work to lower blood sugar in patients with type 2 diabetes by increasing insulin secretion from the pancreas and reducing sugar production. These diabetes pills increase insulin secretion when blood sugars are high. They also tell the liver to stop producing excess amounts of sugar. DPP-IV inhibitors control sugar without causing weight gain. They may be taken alone or with other medications such as metformin. Sodium-glucose co-transporter 2 (SGLT2) inhibitors work by blocking the reabsorption of glucose by the kidney and increasing glucose excretions in urine. The only drugs available in this category are Farxiga (dapagliflozin) and Invokana (canaglifozin). Other drugs are being developed. Combination therapy: There are several combination diabetes pills that combine two medications into one tablet. One example of this is Glucovance, which combines glyburide (a sulfonylurea) and metformin. Others include Metaglip, which combines glipizide (a sulfonylurea) and metformin, and Avandamet, which uses both metformin and rosiglitazone (Avandia) in one pill. Kazano (alogliptin and metformin) and Oseni (alogliptin plus pioglitazone) are other examples. Studies have shown that some diabetes pills may help prevent diabetes and diabetes-related complications. Both metformin and Precose have been shown to reduce a person's risk of developing type 2 diabetes, particularly when combined with lifestyle changes such as a proper diet and regular exercise program. Actos has been shown to reduce the risk of heart attack, stroke, and premature death in those with type 2 diabetes. Researchers continue to look into the preventative benefits of other medications.

Market Analysis:

In a grim reminder of the rise of lifestyle diseases, particularly diabetes, an anti-diabetic molecule has for the first time become the largest-selling formulation in the domestic pharma retail market. Widely-prescribed anti-diabetic drugs (glimepiride plus metformin) clocked sales of Rs 105 crore, surpassing the anti-infective therapy at Rs 103 crore, in the pharma retail market valued at Rs 6,636 crore, in May this year. Analysts tracking the market said the anti-infective therapy had always been ranked on top.

International symposium and workshops

  • 6th Global Diabetes Summit and Medicare Expo, November 02-04, 2015 Dubai, UAE
  • International Conference on Targeting Diabetes and Novel Therapeutics September 14-16, 2015 Las Vegas, Nevada, USA
  • 8th Euro Global Diabetes Summit and Medicare Expo November 03-05, 2015 Valencia, Spain

List of Best International Conferences:

  1. 7th Diabetes Conference, November 23-25, 2015Bengaluru, India
  2. 4th NephrologyTherapeutics Conference September 14-16, 2015Baltimore, USA
  3. 3rd Endocrinology Conference,  November 02-04, 2015Atlanta, USA
  4. Targeting Diabetes and Novel Therapeutics Conference, September 14-16, 2015Las Vegas, USA
  5. 6th Diabetes Conference and Medicare Expo November 02-04, 2015Dubai, UAE
  6. 8th Diabetes ConferenceNovember 03-05, 2015Valencia, Spain
  7. 4th Bioavailability & Bioequivalence Conference August 29-31, 2016 Atlanta, USA
  8. 4th Medicinal Chemistry and CADD ConferenceNovember 02-04, 2015 Atlanta, USA
  9. 2nd Green Chemistry Conference  September 14-16, 2015 Orlando, USA
  10. 2nd Drug Discovery & Designing Conference Oct 31-Nov 02, 2016 Istanbul, Turkey
  11. Precision Medicine Conference November 03-05, 2016 Baltimore, USA
  12. Metabolic Syndrome Conference October 20-22, 2016 Dubai, UAE
  13. 3rd World Congress on Interventional Therapies for Type 2 Diabetes, 28 Sep 2015 to 30 Sep 2015, London, UK
  14. Metabolic & Endocrine Disease Summit Meds East, 7 Oct 2015 to 10 Oct 2015, Orlando, FL USA
  15. 10th Annual Cardiometabolic Health Congress, 21 Oct 2015 to 24 Oct 2015, Boston, MA, USA
  16. 5th World Congress on Controversies to Consensus In Diabetes, Obesity And Hypertension, 5 Nov 2015 to 7 Nov2015, Istanbul, Turkey,
  17. Brazilian Diabetes Society XX Congress 2015, 11 Nov 2015 to 13 Nov2015, Porto Alegre - RS - Brazil

Relevant Society and Associations

  • American Association of Clinical Endocrinologists
  • American Association of Endocrine Surgeons
  • American Diabetes Association
  • American Society of Endocrine Physician Assistants
  • American Thyroid Association
  • Association for Program Directors in Endocrinology, Diabetes and Metabolism
  • Diabetes Australia
  • American Diabetes Association 
  • Canadian Diabetes Association
  • National Aboriginal Diabetes Association
  • Finnish Diabetes Association


  • Sanofi-Aventis
  • Merck & Co., Inc.
  • Novo Nordisk
  • Adley Labs Ltd
  • EGAN Medical Equipment & Supply
  • Adley Labs Ltd
  • West-Coast pharmaceutical works ltd
  • Takeda Pharmaceuticals
  • Genzyme
  • Diabetic Care

This page will be updated regularly.

This page was last updated on December 6, 2021

Conference Series LLC LTD Destinations